Exact Sciences' Cologuard Included as Alternative Screening Test under Draft USPSTF Guidelines

Loading...
Loading...
Exact Sciences
EXAS
issued the following statement today following the U.S. Preventive Services Task Force (USPSTF) draft recommendation statement for colorectal cancer screening. USPSTF included Cologuard in the draft guidelines as an alternative screening test, along with CT colonography. The draft guidelines recommend an "A" rating for colorectal cancer screening starting at age 50 and continuing until age 75. Screening for individuals age 75 through 85 is graded a "C." This approach represents a change from the 2008 recommendations, which assigned specific grades for different tests, including an "I" rating for stool-based DNA. Cologuard is a non-invasive, FDA-approved colorectal cancer screening
See full press release
Market News and Data brought to you by Benzinga APIs
Posted In: NewsContractsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...